Abstract

For prostate cancer as for many other solid tumors, cancer treatments are constantly and rapidly evolving. The primary goals remain, however, the same: to allow patients to live longer and to live better (1). Clinical benefit integrates, in fact, treatment effectiveness as well as assessment of quality of life (QoL).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call